Division of Infectious Diseases & Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1053-1059. doi: 10.1017/ice.2020.1358. Epub 2020 Dec 9.
We assessed the magnitude of unidentified coronavirus disease 2019 (COVID-19) in our healthcare personnel (HCP) early in the COVID-19 pandemic, and we evaluated risk factors for infection to identify areas for improvement in infection control practice in a northern California academic medical center.
We reviewed anti-severe acute respiratory coronavirus virus 2 (SARS-CoV-2) receptor-binding domain (RBD) IgG serologic test results and self-reported risk factors for seropositivity among 10,449 asymptomatic HCP who underwent voluntary serology testing between April 20 and May 20, 2020.
In total, 136 employees (1.3%) tested positive for SARS-CoV-2 IgG. This included 41 individuals (30.1%) who had previously tested positive for SARS-CoV-2 by nasopharyngeal reverse-transcription polymerase chain reaction (RT-PCR) between March 13 and April 16, 2020. In multivariable analysis, employees of Hispanic ethnicity (odds ratio [OR], 2.01; 95% confidence interval [CI], 1.22-3.46) and those working in environmental services, food services, or patient transport (OR, 4.81; 95% CI, 2.08-10.30) were at increased risk for seropositivity compared to other groups. Employees reporting a household contact with COVID-19 were also at higher risk for seropositivity (OR, 3.25; 95% CI, 1.47-6.44), but those with a work, exposure alone were not (OR, 1.27; 95% CI, 0.58-2.47). Importantly, one-third of seropositive individuals reported no prior symptoms, no suspected exposures, and no prior positive RT-PCR test.
In this study, SARS-CoV-2 seropositivity among HCP early in the northern California epidemic appeared to be quite low and was more likely attributable to community rather than occupational exposure.
我们在 COVID-19 大流行早期评估了我们的医疗保健人员(HCP)中未识别的 2019 年冠状病毒病(COVID-19)的规模,并评估了感染的危险因素,以确定在加利福尼亚北部学术医疗中心感染控制实践中需要改进的领域。
我们回顾了 2020 年 4 月 20 日至 5 月 20 日期间接受自愿血清学检测的 10449 名无症状 HCP 的抗严重急性呼吸冠状病毒 2(SARS-CoV-2)受体结合域(RBD)IgG 血清学检测结果和自我报告的血清阳性危险因素。
共有 136 名员工(1.3%)的 SARS-CoV-2 IgG 检测呈阳性。这包括 41 名个体(30.1%),他们在 2020 年 3 月 13 日至 4 月 16 日之间通过鼻咽逆转录聚合酶链反应(RT-PCR)先前检测出 SARS-CoV-2 阳性。在多变量分析中,西班牙裔员工(比值比[OR],2.01;95%置信区间[CI],1.22-3.46)和从事环境服务、食品服务或患者运输的员工(OR,4.81;95%CI,2.08-10.30)与其他群体相比,血清阳性的风险增加。报告与 COVID-19 有家庭接触的员工也有更高的血清阳性风险(OR,3.25;95%CI,1.47-6.44),但仅工作、暴露于 COVID-19 无接触的员工则没有(OR,1.27;95%CI,0.58-2.47)。重要的是,三分之一的血清阳性个体报告没有先前症状、没有可疑暴露且没有先前的 RT-PCR 检测阳性。
在这项研究中,加利福尼亚北部疫情早期 HCP 中的 SARS-CoV-2 血清阳性率似乎相当低,更可能归因于社区而不是职业暴露。